da Cruz Filipa P, Newberry Scott, Jenkinson Sarah F, Wormald Mark R, Butters Terry D, Alonzi Dominic S, Nakagawa Shinpei, Becq Frederic, Norez Caroline, Nash Robert J, Kato Atsushi, Fleet George W J
Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.
Tetrahedron Lett. 2011 Jan 12;52(2):219-223. doi: 10.1016/j.tetlet.2010.10.173.
The syntheses of 4-C-Me-DAB [1,4-dideoxy-1,4-imino-4-C-methyl-d-arabinitol] from l-erythronolactone and of 4-C-Me-LAB [from d-erythronolactone] require only a single acetonide protecting group. The effect of pH on the NMR spectra of 4-C-Me-DAB [pK(a) of the salt around 8.4] is discussed and illustrates the need for care in analysis of both coupling constants and chemical shift. 4-C-Me-DAB (for rat intestinal sucrase K(i) 0.89 μM, IC(50) 0.41 μM) is a competitive - whereas 4-C-Me-LAB (for rat intestinal sucrase K(i) 0.95 μM, IC(50) 0.66 μM) is a non-competitive - specific and potent α-glucosidase inhibitor. A rationale for the α-glucosidase inhibition by DAB, LAB, 4-C-Me-DAB, 4-C-Me-LAB, and isoDAB - but not isoLAB - is provided. Both are inhibitors of endoplasmic reticulum (ER) resident α-glucosidase I and II.
从l-赤藓糖内酯合成4-C-甲基-DAB[1,4-二脱氧-1,4-亚氨基-4-C-甲基-D-阿拉伯糖醇]以及从d-赤藓糖内酯合成4-C-甲基-LAB仅需一个丙酮叉保护基。讨论了pH对4-C-甲基-DAB(盐的pK(a)约为8.4)核磁共振谱的影响,这表明在分析耦合常数和化学位移时都需要谨慎。4-C-甲基-DAB(对大鼠肠道蔗糖酶的K(i)为0.89 μM,IC(50)为0.41 μM)是一种竞争性抑制剂,而4-C-甲基-LAB(对大鼠肠道蔗糖酶的K(i)为0.95 μM,IC(50)为0.66 μM)是一种非竞争性特异性强效α-葡萄糖苷酶抑制剂。文中给出了DAB、LAB、4-C-甲基-DAB、4-C-甲基-LAB和异-DAB(但不是异-LAB)抑制α-葡萄糖苷酶的原理。二者都是内质网(ER)驻留α-葡萄糖苷酶I和II的抑制剂。